论文部分内容阅读
目的观察探讨波立维联合银丹心脑通软胶囊治疗非ST段抬高型急性心肌梗死的临床疗效,总结其临床应用价值。方法选取我院2009年9月至2011年9月54例非ST段抬高型急性心肌梗死的患者,随机分为观察组与对照组,各27例,均给予常规治疗,对照组在常规治疗基础上采取波立维治疗,观察组在常规治疗基础上采取波立维联合银丹心脑通软胶囊治疗,观察对比患者的治疗效果。结果观察组总有效率为92.6%;对照组总有效率为70.4%,两组疗效对比差异具有统计学意义(P<0.05);两组不良反应发生率对比差异无统计学意义(P>0.05)。结论波立维联合银丹心脑通软胶囊治疗非ST段抬高型急性心肌梗死的临床疗效显著,优于单用波立维治疗,能够有助于缓解心肌缺血的症状,改善心功能,不良反应小,安全可靠,值得临床合理推广应用。
Objective To observe the clinical efficacy of Boliwei combined with Yindan Xinnaotong soft capsule in the treatment of non-ST segment elevation acute myocardial infarction and to summarize its clinical value. Methods From September 2009 to September 2011, 54 cases of non-ST-segment elevation acute myocardial infarction were randomly divided into observation group and control group, 27 cases in each group, all of whom were given routine treatment. The control group received routine treatment Based on the wave-dimensional treatment, the observation group in the conventional treatment based on wave-dimensional joint Yin Dan Xinnaotong soft capsule treatment, the observed and compared the therapeutic effect of patients. Results The total effective rate in the observation group was 92.6%; the total effective rate in the control group was 70.4%, the difference between the two groups was statistically significant (P <0.05); There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05 ). Conclusion The clinical effect of Boliwei combined with Yindan Xinnaotong soft capsule in the treatment of non-ST-segment elevation acute myocardial infarction is better than that of single-wave poli-dimensional treatment, which can relieve the symptoms of myocardial ischemia, improve cardiac function, Small reaction, safe and reliable, it is worth to promote clinical application.